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false-positive screening in breast cancer and lung cancer.
However, several new lung-speciﬁc items were needed to obtain
high content coverage and, consequently, make the COS-LC
relevant to lung cancer screening. The questionnaire is currently
in use in the Danish randomised study and will be validated using
Item Response Theory (the Rasch model).
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OBJECTIVES: The purpose is to prospectively describe factors
that may inﬂuence the choice between surgery, radiation, and
watchful waiting among men newly diagnosed with local stage
prostate cancer. METHODS: Beginning in December 2005, pros-
tate cancer patients were approached shortly after diagnosis at
urology clinics in Texas, California and South Carolina. Patients
took home a self-administered survey to complete as they made
their treatment decision. Preliminary data are available for 148
men with recruitment continuing through 2007. Logistic regres-
sion was used to identify factors associated with choice of treat-
ment. RESULTS: Overall 65% of men returned the survey before
starting treatment. A total of 82% indicated they were only
considering (or had considered) a single option; 64% were only
considering surgery, 9% were only considering radiation, 9%
were only considering non-curative therapies, and 18% were
considering multiple options or were unsure of their decision.
Being married (OR 4.7; 95% CI: 1.1, 19.4), being under age 70
(OR 2.7; 95% CI: 1.0, 7.0), and having an annual household
income higher than $60,000 (OR 2.9; 95% CI: 1.0, 8.1) were
strongly associated with considering surgery only. CONCLU-
SION: Understanding why most men feel their only option is
surgery is a priority to ensure that physician biases, patient
misperceptions, or fear do not lead patients to select procedures
that do not agree with their personal preferences. Many patients
appear to make rapid treatment decisions. Interventions to aid
treatment decision-making must target men soon after they
receive their diagnosis.
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OBJECTIVES: To measure and compare preferences for
attributes of colorectal cancer (CRC) screening tests using a
stated preference survey of the general population and physicians
in Canada and the United States (US). METHODS: A stated
preference survey was administered online with 11 choice tasks
between two hypothetical CRC screening tests. Each test was
described by nine attributes: process, pain, preparation, fre-
quency, follow-up, complication risk, sensitivity, speciﬁcity, and
out-of-pocket cost. Each scenario included a follow-up opt-out
question to choose no screening. A total of 1087 US and
501 Canadian respondents participated and 100 physicians
responded in both countries. Physicians were asked to indicate
their patients’ preferences. Responses were modeled using bivari-
ate regression with main effects and interactions with the optout
term. Willingness-to-pay was calculated for common CRC
screening tests. RESULTS: Physicians expected patients to choose
the option of ’no screening’ more frequently than patients them-
selves (55% vs 29% respectively, p < 0.001). For all groups the
most important attribute was sensitivity, but physicians’ percep-
tion of patients’ preferences were signiﬁcantly different from
actual patient preferences. Other key attributes were those
related to test performance or the testing process. Fecal DNA,
colonoscopy, and virtual colonoscopy were the most preferred
tests by all groups, but respondents were willing-to-pay more
than physicians predicted. CONCLUSION: Physicians’ percep-
tion of patients’ preferences are signiﬁcantly different from those
of the general population, although both preferred tests with
high sensitivity. The signiﬁcant difference in the frequency of
choosing no screening between physicians and their patients may
have serious implications for CRC screening uptake since physi-
cians generally exert a strong inﬂuence on decisions about health
care treatment, and especially screening programs. Among
general population and physicians, Canadian and US respon-
dents’ preferences were similar.
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OBJECTIVES: Intra-ocular pressure (IOP) ﬂuctuation over 24
hours is an independent risk factor for glaucoma progression.
Night-time IOP measurement is not a routine practice. The aim
of this study was to predict the risk of a nocturnal IOP peak from
day-time measurements. METHODS: IOP measurements from
three clinical trials were pooled. The night-time IOP peak was
deﬁned as the maximum value observed between 00:00 h and
04:00 h. IOP measurements at 08:00 h, 12:00 h, 16:00 h, and
20:00 h were dichotomized using four thresholds: 15, 18, 21,
and 25 mmHg. Patient IOPs were assessed during pre-treatment
washout periods and after treatment with a prostaglandin ana-
logue (PGA: latanoprost or travoprost). A Bayesian network
(BN), adjusted for trial effects, was constructed to study the
association between day-time IOP, nocturnal IOP, and treatment
effects at each of the four thresholds. RESULTS: In total, 382
daily IOP vectors were identiﬁed (pre-treatment: 208; PGA: 174).
The BN association structures differed according to threshold
value. A direct drug effect on the night peak associated with IOP
control at 12:00 was required for a 15 mmHg night IOP target.
Control of IOP at 12:00 and 20:00 was associated with night
control for an 18 mmHg target, at 8:00 and 20:00 for 21 and
25 mmHg targets. Both PGAs were effective in controlling night-
time IOP after it was controlled during the day. Night-time IOP
responder rate differences (pre-treatment minus treatment) pre-
dicted by the BN were 28.7% for the 15 mmHg target, 44.9%
for the 18 mmHg target, 54.0% for the 21 mmHg target, and
9.4% for the 25 mmHg target. CONCLUSION: Day-time IOP
measurements are highly inter-correlated and BNs can help to
predict nocturnal IOP control from day-time measurements. BN
A346 Abstracts
